https://www.lbbwvc.de/contact-us/
Contact - LBBW Venture Capital
May 7, 2024 - Email: future@lbbwvc.de
lbbw venturecapital
https://www.lbbwvc.de/portfolio/specter-automation/
Specter Automation - LBBW Venture Capital
specter automation develops an assistance system for construction management that puts 3D models at the center of the construction site and automates
lbbw venturespecterautomationcapital
https://www.lbbwvc.de/portfolio/epignostix/
Epignostix - LBBW Venture Capital
Combining world-leading scientific and medical expertise with cutting-edge technical innovation, to improve diagnostic accuracy and enhance clinical care for
lbbw venturecapital
https://www.lbbwvc.de/portfolio/phenex/
Phenex - LBBW Venture Capital
Phenex focuses its small-molecule drug discovery expertise in Liver diseases and in Cancer. Phenex aim is to translate novel scientific findings into
lbbw venturecapital
https://www.lbbwvc.de/portfolio/threedy/
Threedy - LBBW Venture Capital
Threedy is an innovative high-tech start-up founded in 2020 as a spin-off from Fraunhofer’ s Institute for Applied Computer Graphics Research (IGD) in
lbbw venturecapital
https://www.lbbwvc.de/portfolio/debtvision/
Debtvision - LBBW Venture Capital
Founded in 2018 as a joint subsidiary of the market leader for Schuldscheindarlehen, the Landesbank Baden-Württemberg (LBBW), and the Börse Stuttgart GmbH,
lbbw venturecapital
https://www.lbbwvc.de/portfolio/acousia/
Acousia Therapeutics - LBBW Venture Capital
Acousia is developing drugs for local application, which will restore hearing in patients who have lost their hearing ability induced by various reasons,
lbbw venturetherapeuticscapital
https://www.lbbwvc.de/portfolio/3yourmind/
3yourmind - LBBW Venture Capital
3YOURMIND’s hardware agnostic solution offers all necessary modules (PLM, ERP, MES) in order to identify 3d-printable parts (digital qualified inventory) as
lbbw venturecapital
https://www.lbbwvc.de/portfolio/teralytics/
Teralytics - LBBW Venture Capital
The Teralytics approach transforms transportation planning and operations by providing up-to-date mobility insights of unprecedented accuracy and inclusiveness.
lbbw ventureteralyticscapital
https://www.lbbwvc.de/portfolio/licit/
LICIT Solutions - LBBW Venture Capital
Next-Generation Active Ingredients for Preservation, Hygiene, and Protection
lbbw venturesolutionscapital
https://www.lbbwvc.de/
LBBW Venture Capital
May 7, 2024 - We help brilliant teams with a strong moat to establish visionary market leaders.
lbbw venturecapital
https://www.lbbwvc.de/portfolio/aiperia/
AIPERIA - LBBW Venture Capital
AIPERIA, founded in 2021 is an AI-based planning platform that enables food producers and suppliers to open up new distribution channels, achieve better
lbbw venturecapital
https://www.lbbwvc.de/imprint/
Imprint - LBBW Venture Capital
Oct 24, 2025 - Der Vergütungsbericht für 2024 ist abrufbar unter:
lbbw ventureimprintcapital
https://www.lbbwvc.de/portfolio/crealytics/
Crealytics - LBBW Venture Capital
Crealytics is a retail performance advertising company. Using a combination of proprietary technology and world-class service, Crealytics helps eCommerce
lbbw venturecapital
https://www.lbbwvc.de/portfolio/code-intelligence/
Code Intelligence - LBBW Venture Capital
Critical vulnerabilities and bugs can be identified earlier and, hence, they are substantially quicker and cheaper to fix. The company uses modern fuzzing
lbbw venturecodeintelligencecapital
https://www.lbbwvc.de/portfolio/impossible-cloud/
Impossible Cloud - LBBW Venture Capital
Impossible Cloud, founded in 2021, is an innovator in cloud computing and redefines cloud services with cost-effective, intelligent storage solutions and a
lbbw ventureimpossiblecloudcapital
https://www.lbbwvc.de/portfolio/
Portfolio - LBBW Venture Capital
May 18, 2025 - We establish new partnerships with exceptional founders. They embrace the grind needed to bring awesome products and companies to life.
lbbw ventureportfoliocapital
https://www.lbbwvc.de/portfolio/umlaut-bio/
Umlaut.bio - LBBW Venture Capital
Decoding RNA Modifications to revolutionize cancer and inflammation treatment
lbbw venturebiocapital
https://www.lbbwvc.de/portfolio/meshcapade/
Meshcapade - LBBW Venture Capital
Meshcapade: Redefining Digital Humans with AI and Cutting-Edge Research
lbbw venturecapital
https://www.lbbwvc.de/legalnotice/
Legal Notice - LBBW Venture Capital
Jan 14, 2026 - For information on how to submit and how we handle complaints, please refer to our Complaint Management Principles (PDF, 1 MB, Direct-Download) .
legal noticelbbw venturecapital
https://www.lbbwvc.de/portfolio/cortec/
CorTec - LBBW Venture Capital
As innovation leaders in neurotechnology CorTec endow the development of new therapies: Either CorTec develop and manufacture single individual components
lbbw venturecorteccapital
https://www.lbbwvc.de/portfolio/exciva/
Exciva - LBBW Venture Capital
Exciva GmbH is a Heidelberg-based biopharmaceutical company founded in 2016, applying a transformational approach for clinical care of Alzheimer's disease
lbbw venturecapital
https://www.lbbwvc.de/portfolio/actitrexx/
ActiTrexx - LBBW Venture Capital
Actitrexx, a spin-off from the University Mainz, develops ATreg, a cellular therapy with activated regulatory T cells produced within 24hrs by a proprietary
lbbw venturecapital